Abstract
BackgroundData is needed about barriers to self-collection of Human Papillomavirus (HPV) samples and cytology among low-income, disadvantaged women living in rural areas of lower-income countries as these women are at increased risk of cervical cancer mortality.MethodsIndividual interviews (n = 29), focus groups (n = 7, 5–11 participants) and discussion groups (n = 2, 18–25 participants) were organized with women from three indigenous ethnic groups residing in rural areas in Mexico, after they were provided with free, self-sampled HPV tests. These groups are low-income, underserved by healthcare and have historically been on the receiving end of racism and social exclusion. Descriptive, qualitative content analysis was done, including two cycles of coding.ResultsInterview and focus/discussion group data indicate women had limited understanding of HPV’s role in cervical cancer etiology. They identified HPV’s existence, that cytology detects cervical cancer, the need for regular testing and that cervical cancer is sexually transmitted. Organizational barriers to clinic-based cytology included irregular supplies of disposable speculums, distance to clinics and lack of clear communication by healthcare personnel. Women considered self-collected HPV-testing easy, less embarrassing and less painful than cytology, an opportunity for self-care and most felt they understood how to take a self-sample after a 20-min explanation. Some women feared hurting themselves when taking the self-sample or that they would take the sample incorrectly, which they worried would make the test useless. Attending HPV-testing in groups facilitated use by allowing women to discuss their doubts and fears before doing self-collection of the sample or to ask other women who were the first to do the self-sampling what the experience had been like (whether it hurt and how easy it was). Lack of indoor bathrooms was a barrier to doing HPV self-sampling at home, when those homes were resource-poor (one-room dwellings).ConclusionsLow-income, indigenous Mexican women residing in rural, underserved areas identified their need for cervical cancer screening but encountered multiple barriers to cytology-based screening. They found a number of advantages of HPV self-sampled tests. Employing self-collected HPV-testing instead of cytology could resolve some but not all gender-related, organizational or technical quality-of-care issues within cervical cancer detection and control programs.
Highlights
Data is needed about barriers to self-collection of Human Papillomavirus (HPV) samples and cytology among low-income, disadvantaged women living in rural areas of lower-income countries as these women are at increased risk of cervical cancer mortality
Given the advantages of HPV testing for lower-income countries with high cervical cancer mortality, low coverage and quality-control problems [8, 11, 14,15,16], where risk of dying of cervical cancer is often greater among women in rural and underserved communities [4, 6, 7], our objective was to study barriers to use of selfsampled HPV testing and cytology among low-income, indigenous women residing in rural areas of Mexico
Results are organized around the following themes: perceptions, beliefs and knowledge about cervical cancer and HPV; perceptions, knowledge and experiences related to cytology; barriers to cervical cancer screening using cytology; gender barriers and acceptability of the self-collected HPV test; perceived advantages of the self-sampled HPV test
Summary
Data is needed about barriers to self-collection of Human Papillomavirus (HPV) samples and cytology among low-income, disadvantaged women living in rural areas of lower-income countries as these women are at increased risk of cervical cancer mortality. Lower screening coverage is associated with disparities which can constitute barriers to testing, including lower income and education, residence in rural or low human development index areas, belonging to indigenous groups or language and cultural barriers [4,5,6,7]. Beyond coverage, continued high cervical cancer mortality rates in lower-income countries are often due to inefficient screening programs [8]. Implementation of high-risk human papillomavirus (HPV) tests in screening programs could reduce mortality through more efficient early detection and treatment [8,9,10,11]. Studies have shown high acceptability of selfsampled HPV tests with increased participation by nonparticipating women [14, 15]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.